Inside Drug Pricing

As stakeholders press for permanent telehealth changes,

Trump Asks Which COVID-19 Waivers Would Help Economy If Permanent

By Michelle M. Stein / May 19, 2020 at 8:19 PM

President Donald Trump on Tuesday (May 19) directed federal agencies to come up with a list of COVID-19 regulatory waivers and flexibility that would help the economy if made permanent, as he signed an executive order during a cabinet meeting during which he suggested some coronavirus regulatory relief could be extended.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

As stakeholders press for permanent telehealth changes,

Trump Asks Which COVID-19 Waivers Would Help Economy If Permanent

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.